Discover and read the best of Twitter Threads about #hct
Most recents (2)
#TCTM21 Significantly worse EFS and higher incidence of graft failure among #SickleCell disease patients undergoing #BMTsm on Medicaid compared to private insurance - Very important study from @CIBMTR by Tatenda Geraldine Mupfudze and colleagues tct.confex.com/tct/2021/meeti…
Similar trend in #BMTsm utilization in adult acute leukemia patients’ - public insurance, race and older age has significant influence on #HCT utilization, abstract by Silas Day #TCTM21 tct.confex.com/tct/2021/meeti…
#TCTM21 Naseem Esteghamat identified disparities in auto #HCT utilization, specifically among African Americans vs Whites (OR: 0.68), patients covered on Medicare or Medicaid vs private insurance (OR: 0.79), and those with lower SES (OR: 0.71). tct.confex.com/tct/2021/meeti…
What happens to hematopoietic transplant recipients who develop #COVID19?
Transplant recipients and transplanters have been asking this question ever since the pandemic began.
Our analysis using @CIBMTR data is out today in @TheLancetHaem thelancet.com/journals/lanha…. 1/
Transplant recipients and transplanters have been asking this question ever since the pandemic began.
Our analysis using @CIBMTR data is out today in @TheLancetHaem thelancet.com/journals/lanha…. 1/
While there have been close to 100,000 papers related to COVID-19 listed on @NCBI @NLM_NIH #Pubmed, there are very few that address outcomes after #COVID19 in #BMTsm patients, a few are listed in the next tweet: 2/
1. Spanish experience from @GETH_info onlinelibrary.wiley.com/doi/10.1002/pb…
2. Chicago (@RushMedical, @UChicago & @NUFeinbergMed) & New York City (@MountSinaiNYC) experience in @LeukemiaJnl nature.com/articles/s4137…
3. @sloan_kettering experience in @jclinicalinvest jci.org/articles/view/… 3/
2. Chicago (@RushMedical, @UChicago & @NUFeinbergMed) & New York City (@MountSinaiNYC) experience in @LeukemiaJnl nature.com/articles/s4137…
3. @sloan_kettering experience in @jclinicalinvest jci.org/articles/view/… 3/
